Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 43

    OPOS, Fullpower enter partnership to create-The First 24/7 Opioid Compliance Solution

    OPOS, Fullpower enter partnership to create-The First 24/7 Opioid Compliance Solution

    Medical Dialogues Bureau5 Jan 2020 3:30 AM
    New Delhi: Fullpower Technologies, the sleep technology company and OPOS, the opioid optimization company” announced a partnership to create “The...
    Patent Infringement: Case against Natco Pharma in US court over generic version of cancer drug Lonsurf

    Patent Infringement: Case against Natco Pharma in US court over generic version of cancer drug Lonsurf

    Medical Dialogues Bureau4 Jan 2020 8:33 AM
    In a petition filed in the United States District Court for the District Court of Delaware on December 30, Taiho alleged that the Natco Pharma's...
    Dr Reddys secures shareholders nod for amalgamation of Dr Reddys Holdings into company

    Dr Reddys secures shareholders nod for amalgamation of Dr Reddys Holdings into company

    Medical Dialogues Bureau4 Jan 2020 7:20 AM
    The board of Dr Reddy's Laboratories had on July 29, 2019, approved the amalgamation of Dr Reddy's Holdings Ltd, an entity held by the promoter group...
    Novo Nordisk to offer free insulin to US patients

    Novo Nordisk to offer free insulin to US patients

    Medical Dialogues Bureau4 Jan 2020 4:00 AM
    Novo Nordisk said in September U.S. patients can buy three vials or two packs of pens of its analogue insulins for $99, following similar moves by...
    Merck, Novartis, Allergan to raise US drug prices for 100 drugs

    Merck, Novartis, Allergan to raise US drug prices for 100 drugs

    Medical Dialogues Bureau4 Jan 2020 3:50 AM
    New Delhi: Novartis AG, Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription medicines on...
    Sonoco acquires healthcare packaging, medical device thermoformer-TEQ for USD 187 million

    Sonoco acquires healthcare packaging, medical device thermoformer-TEQ for USD 187 million

    Farhat Nasim4 Jan 2020 3:45 AM
    Sonoco funded the TEQ transaction using short-term credit facilities and it is expected to be accretive to Sonoco’s 2020 earnings. New Delhi: Sonoco,...
    Karnataka: Around 2000 Govt Pharmacists launch protest, threaten indefinite strike

    Karnataka: Around 2000 Govt Pharmacists launch protest, threaten indefinite strike

    Farhat Nasim3 Jan 2020 11:49 AM
    The protest in Karnataka is likely to take a major turn as the association is of the view that if the government fails to fulfil their demands,...
    Novo Nordisk names Vikrant Shrotriya as Managing Director for India business

    Novo Nordisk names Vikrant Shrotriya as Managing Director for India business

    Medical Dialogues Bureau3 Jan 2020 8:51 AM
    Vikrant Shrotriya was recently working in the GCC (Gulf Cooperation Council) countries wherein he was Vice-President for company's GCC business and...
    Aurobindo Pharma recalls Mirtazapine tablets in US over labelling error

    Aurobindo Pharma recalls Mirtazapine tablets in US over labelling error

    Medical Dialogues Bureau3 Jan 2020 7:37 AM
    Bottles labelled as Mirtazapine 7.5 mg may contain 15 mg tablets, as per Aurobindo Pharma's announcement posted on the website of the United States...
    Pacific Biosciences, Illumina cancel USD 1.2 billion deal

    Pacific Biosciences, Illumina cancel USD 1.2 billion deal

    Medical Dialogues Bureau3 Jan 2020 4:00 AM
    Gene sequencing company Illumina would pay Pacific Biosciences $98 million for the terminated deal, which was announced in 2018 and had attracted...
    MSN Labs subsidiary Novadoz Pharma gets USFDA nod for generic Uloric

    MSN Labs subsidiary Novadoz Pharma gets USFDA nod for generic Uloric

    Medical Dialogues Bureau3 Jan 2020 3:45 AM
    New Delhi: Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, has received FDA approval...
    11 Drugs Controller Officers appointed in Punjab; Details

    11 Drugs Controller Officers appointed in Punjab; Details

    Farhat Nasim2 Jan 2020 10:16 AM
    "Now with the recruitment of these 11 drugs controller officers, the FDA would expedite the action against the chemists who are indulging in unethical...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok